MedPal AI is a UK-based digital health company specialising in AI-driven wellness management and online pharmacy operations. • Shares amongst the best performing on AIM since August IPO as rapid progress made MedPal AI listed on AIM on 26th August 2025 alongside a fundraise of £2 million (£1.65 million net) at 4p per share. Since then, the firm has already managed to expand its operations markedly via the acquisition of certain assets from Universal Pharmacy, which came with a UK Distance Selling Pharmacy (DSP) licence. Another £0.545 million was raised alongside the Universal deal, at 8p per share, to fund expansion of the DSP business. • AI driven consumer app to target rapid growth in health & fitness